Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016

详细信息    查看全文

• 作者：Hidehisa Saeki ; Takeshi Nakahara ; Akio Tanaka ; Kenji Kabashima ; Makoto Sugaya ; Hiroyuki Murota ; Tamotsu Ebihara ; Yoko Kataoka ; Michiko Aihara ; Takafumi Etoh ; Norito Katoh and Committee for Clinical Practice Guidelines for the Management of Atopic Dermatitis of Japanese Dermatological Association
• 刊名：The Journal of Dermatology
• 出版年：2016
• 出版时间：October 2016
• 年：2016
• 卷：43
• 期：10
• 页码：1117-1145
• 全文大小：453K
• ISSN：1346-8138

文摘

Atopic dermatitis (AD) is a disease characterized by relapsing eczema with pruritus as a primary lesion. Most patients have an atopic predisposition. The definitive diagnosis of AD requires the presence of all three features: (i) pruritus; (ii) typical morphology and distribution of the eczema; and (iii) chronic and chronically relapsing course. The current strategies to treat AD in Japan from the perspective of evidence-based medicine consist of three primary measures: (i) the use of topical corticosteroids and tacrolimus ointment as the main treatment for the inflammation; (ii) topical application of emollients to treat the cutaneous barrier dysfunction; and (iii) avoidance of apparent exacerbating factors, psychological counseling and advice about daily life. The guidelines present recommendations to review clinical research articles, evaluate the balance between the advantages and disadvantages of medical activities, and optimize medical activity-related patient outcomes with respect to several important points requiring decision-making in clinical practice.